Barinthus Biotherapeutics plc. — All Filings
239 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
3
3/A
4
4/A
424B4
425
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-3
S-3/A
S-8
SC 13G
SC 13G/A
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-K | 10-K | 0001828185-26-000012 | Mar 13, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001828185-26-000011 | Mar 13, 2026 | — |
| 425 | 425 | 0001104659-26-018309 | Feb 23, 2026 | — |
| 8-K | FORM 8-K | 0001104659-26-018283 | Feb 23, 2026 | — |
| 8-K | 8-K | 0001828185-26-000004 | Jan 6, 2026 | Dec 30, 2025 |
| 8-K | 8-K | 0001828185-25-000075 | Dec 10, 2025 | — |
| 10-Q | 10-Q | 0001828185-25-000072 | Nov 7, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001828185-25-000071 | Nov 7, 2025 | — |
| 425 | 425 | 0001104659-25-095011 | Sep 30, 2025 | — |
| 425 | 425 | 0001104659-25-094759 | Sep 30, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-094754 | Sep 30, 2025 | Sep 29, 2025 |
| 8-K/A | FORM 8-K/A | 0001104659-25-075707 | Aug 8, 2025 | Aug 7, 2025 |
| 10-Q | 10-Q | 0001828185-25-000059 | Aug 7, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0001828185-25-000058 | Aug 7, 2025 | — |
| 4 | FORM 4 | 0001828185-25-000049 | Jun 11, 2025 | Jun 10, 2025 |
| 4 | FORM 4 | 0001828185-25-000047 | Jun 11, 2025 | Jun 10, 2025 |
| 4 | FORM 4 | 0001828185-25-000045 | Jun 11, 2025 | Jun 10, 2025 |
| 4 | FORM 4 | 0001828185-25-000043 | Jun 11, 2025 | Jun 10, 2025 |
| 4 | FORM 4 | 0001828185-25-000041 | Jun 11, 2025 | Jun 10, 2025 |
| 4 | FORM 4 | 0001828185-25-000039 | Jun 11, 2025 | Jun 10, 2025 |
| 8-K | FORM 8-K | 0001104659-25-058141 | Jun 10, 2025 | — |
| 10-Q | 10-Q | 0001828185-25-000037 | May 7, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0001828185-25-000036 | May 7, 2025 | May 1, 2025 |
| ARS | ARS | 0001104659-25-039443 | Apr 25, 2025 | Dec 31, 2024 |
| DEFA14A | DEFA14A | 0001104659-25-039433 | Apr 25, 2025 | — |
| DEF 14A | DEF 14A | 0001828185-25-000027 | Apr 25, 2025 | Jun 10, 2025 |
| S-8 | FORM S-8 | 0001104659-25-026203 | Mar 20, 2025 | — |
| 10-K | 10-K | 0001828185-25-000021 | Mar 20, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0001828185-25-000018 | Mar 20, 2025 | — |
| SCHEDULE 13G/A | — | 0001753926-25-000226 | Feb 11, 2025 | — |
| 4 | FORM 4 | 0001828185-25-000012 | Feb 5, 2025 | Feb 3, 2025 |
| 4 | FORM 4 | 0001828185-25-000011 | Feb 5, 2025 | Feb 3, 2025 |
| 4 | FORM 4 | 0001828185-25-000010 | Feb 5, 2025 | Feb 3, 2025 |
| 4 | FORM 4 | 0001828185-25-000009 | Feb 5, 2025 | Feb 3, 2025 |
| 8-K | 8-K | 0001828185-25-000004 | Jan 10, 2025 | — |
| 3/A | OWNERSHIP DOCUMENT | 0001104659-24-132708 | Dec 31, 2024 | Dec 17, 2024 |
| 3 | OWNERSHIP DOCUMENT | 0001104659-24-130804 | Dec 20, 2024 | Dec 17, 2024 |
| 8-K | 8-K | 0001828185-24-000093 | Nov 25, 2024 | — |
| 8-K | 8-K | 0001828185-24-000089 | Nov 15, 2024 | — |
| 10-Q | 10-Q | 0001828185-24-000085 | Nov 6, 2024 | Sep 30, 2024 |
| 8-K | 8-K | 0001828185-24-000083 | Nov 6, 2024 | — |
| SC 13G/A | BARINTHUS BIOTHERAPEUTICS PLC | 0001193125-24-249498 | Nov 1, 2024 | — |
| SC 13G | SC 13G | 0001753926-24-001693 | Oct 15, 2024 | — |
| 8-K | FORM 8-K | 0001104659-24-097364 | Sep 5, 2024 | Sep 1, 2024 |
| 10-Q | 10-Q | 0001828185-24-000075 | Aug 8, 2024 | Jun 30, 2024 |
| 8-K | 8-K | 0001828185-24-000073 | Aug 8, 2024 | — |
| 4 | OWNERSHIP DOCUMENT | 0001104659-24-072802 | Jun 18, 2024 | Jun 3, 2024 |
| 3 | OWNERSHIP DOCUMENT | 0001104659-24-072796 | Jun 18, 2024 | Jun 3, 2024 |
| 8-K | FORM 8-K | 0001104659-24-070834 | Jun 12, 2024 | — |
| 8-K | 8-K | 0001828185-24-000063 | Jun 6, 2024 | — |